City

Singapore (1)

Condition

Adenocarcinomas (1)

Recurrent Gynecological (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

National University Hospital, Singapore (1)

Collaborator

Intervention

pembrolizumab and lenvatinib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

recurrent gynecological

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Adenocarcinomas, Recurrent Gynecological Trial in Singapore (pembrolizumab and lenvatinib)

Recruiting

Adenocarcinomas
Recurrent Gynecological

pembrolizumab and lenvatinib

Singapore, Singapore

National University Hospital

Oct 13, 2021